Story perspectives

Nabsys Unveils Breakthrough Genetic Tool at Human Genetics Meeting

10/17/2025

Summary

Story summary

Nabsys 2.0, LLC presented findings at the American Society of Human Genetics Annual Meeting in Boston, October 14-18, 2025.
Nabsys showcased its OhmX Platform, which enhances structural variant detection in undiagnosed disorders and hematological malignancies.
The study found that 70% of patients with interstitial cystitis/bladder pain syndrome have psychiatric comorbidities, with associations to Mendelian disease genes.
The research used electronic genome mapping (EGM) and CRISPR/Cas9 to improve genomic analysis.

1 of 1

Story summary

Nabsys 2.0, LLC presented findings at the American Society of Human Genetics Annual Meeting in Boston, October 14-18, 2025.
Nabsys showcased its OhmX Platform, which enhances structural variant detection in undiagnosed disorders and hematological malignancies.
The study found that 70% of patients with interstitial cystitis/bladder pain syndrome have psychiatric comorbidities, with associations to Mendelian disease genes.
The research used electronic genome mapping (EGM) and CRISPR/Cas9 to improve genomic analysis.